Full genome characterization of hepatitis B virus strains from blood donors in Iran

Journal of Medical Virology

Volumn 83, Issue 6, 2011, Pages 948-952

  Garmiri, Penelope ^a   Rezvan, Houri ^b   Abolghasemi, Hassan ^b   Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Genotyping; Molecular characterization; Phylogeny

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; EGYPT; FEMALE; GENE DELETION; GENOME ANALYSIS; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEROTYPE; STOP CODON; TUNISIA; VIRUS GENOME; VIRUS LOAD; VIRUS MUTATION; VIRUS STRAIN;

ADULT; BASE SEQUENCE; BLOOD DONORS; COHORT STUDIES; DNA, VIRAL; EGYPT; FEMALE; GENOME, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; SEQUENCE ANALYSIS, DNA; TUNISIA; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 79954622188     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21772     Document Type: Article

References (17)

1. Ahmed CS, Wang ZH, Bin Z, Chen JJ, Kamal M, Hou JL. 2009. Hepatitis B virus genotypes, subgenotypes, precore, and basal core promoter mutations in the two largest provinces of Pakistan. J Gastroenterol Hepatol 24:569-573.
2. Alavian SM, Fallahian F, Lankarani KB. 2007. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis 16:403-406.
3. Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, Shyamala V, Yeboah F, Anokwa M, Owusu-Ofori S, Opare-Sem O. 2003. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101:2419-2425.
4. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, Mahboudi F. 2005. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol 76:318-326.
5. André F. 2000. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18:S20-S22.
6. Candotti D, Opare-Sem O, Rezvan H, Sarkodie F, Allain JP. 2006. Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase. J Viral Hepat 13:715-724.
7. Doosti A, Amini-Bavil-Olyaee S, Tajbakhsh E, Adeli A, Mahboudi F. 2009. Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in West Iran. New Microbiol 32:193-198.
8. Kafi-Abad SA, Rezvan H, Abolghasemi H, Talebian A. 2009. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 49:2214-2220.
9. Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, Jafari AM. 2007. Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci 10:4461-4466.
10. Kramvis A, Kew M, François G. 2005. Hepatitis B virus genotypes. Vaccine 23:2409-2423.
11. Meldal B, Mojjat-Moula N, Barnes IHA, Boukef K, Allain JP. 2009. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 90:1622-1628.
12. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Zeid-Abadi-Nejhad M, Hosseini MR, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R. 2009. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: A population-based study. Arch Iran Med 12:225-231.
13. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, Rostami Nejad M, Antikchi MH, Sabahi F, Zali MR. 2008. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect 14:858-866.
14. Ozgenc O, Ozacar T, Erensoy S, Inan N, Ari A, Kuruuzum Z, Bilgic A. 2007. Clinical significance of basal core promoter and precore mutations in chronic hepatitis B. Hepatogastroenterology 54:2319-2323.
15. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, Farrell GC, Locarnini S, George J, Malekzadeh R. 2008. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat 15:753-760.
16. Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T. 2009. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. J Viral Hepat 16:259-264.
17. Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, Allain JP. 2008. Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol 89:409-418.